Not Signed In -
Bupropion |
Wellbutrin |
Clinical Trial: Treatment of Adolescents with Comorbid Alcohol Use and Attention Deficit Hyperactivity Disorder (bupropion)
This study is currently recruiting patients.
|
Purpose
This study will compare the effectiveness of sustained release bupropion (Wellbutrin) versus a placebo in the treatment of adolescents with comorbid alcohol use disorder and attention deficit hyperactivity disorder. Adolescents, ages 14-18 will be recruited from community treatment programs for a 16-week trial with follow-up assessments.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Alcoholism Attention Deficit Hyperactivity Disorder | Drug: bupropion (Wellbutrin) | Phase II |
MedlinePlus related topics: Alcoholism; Attention Deficit Disorder with Hyperactivity
Study Type: Interventional
Study Design: Treatment, Double-Blind, Placebo Control, Parallel Assignment
Official Title: Psychopharmacology of Adolescents with AUD and ADHD
Expected Total Enrollment: 80
Study start: September 2001; Expected completion: September 2006
Eligibility
Ages Eligible for Study: 14 Years - 18 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Meets criteria for alcohol use disorder and attention deficit hyperactivity disorder.
- Adolescents, ages 14-18.
Exclusion Criteria:
- Adolescents who are pregnant.
- Have a history of seizure disorder, other neurological or medical disorder for which medication treatment may present a considerable risk.
- History of pervasive development disorder, schizophrenia or other psychotic disorders, organic mental disorders or eating disorders.
- Currently on other psychotropic medications from which discontinuation would present a significant risk.
- A current episode of major depressive disorder or a diagnosis of bipolar disorder.
- Diagnosis of dependence for any substance other than marijuana.
- Adolescents with a full-scale IQ below 80.
Location and Contact Information
Pennsylvania
Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania, 15213, United States; Recruiting
More Information
Record last reviewed: November 2003
Last Updated: October 13, 2004
Record first received: January 16, 2002
ClinicalTrials.gov Identifier: NCT00029614
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
